NxStage Medical

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success is inspiring patients and providers.
Type
Public
HQ
Lawrence, US
Founded
1998
Size (employees)
3,400 (est)-5%
NxStage Medical was founded in 1998 and is headquartered in Lawrence, US

NxStage Medical Office Locations

NxStage Medical has offices in Lawrence, Lutherville-Timonium, Wakefield, Norwood and in 40 other locations
Lawrence, US (HQ)
350 Merrimack St
Orlando, US
14522 Landstar Blvd
Monroeville, US
3623 William Penn Hwy
Coconut Creek, US
7525 FL-7
Oak Brook, US
1600 16th St
Casselberry, US
d102 174 FL-436
Germantown, US
101 8040 Wolf River Blvd
Jacksonville, US
39 2777 University Blvd W
Lanham, US
100 10003 Derekwood Ln
Macon, US
1625 Hardeman Ave
Dublin, US
5665 Woerner Temple Rd
Brunswick, US
1418 Town Center Blvd
Cincinnati, US
12065 Montgomery Rd
Norwood, US
500 Providence Hwy
Wakefield, US
1 107 Audubon Rd
Lutherville-Timonium, US
h 1940 Greenspring Dr

NxStage Medical Metrics

NxStage Medical Financial Metrics

Revenue (2016)

$366.4 m

Revenue growth (2015-16), %

9%

Gross profit

$152 m

Gross profit margin (2016), %

41%

Net income (2016)

($7.3 m)

Market capitalization (21-Mar-2017)

$1.8 b

Closing share price (21-Mar-2017)

$27.6

Cash (31-Dec-2016)

$59.6 m
NxStage Medical's current market capitalization is $1.8 b.
NxStage Medical's revenue was reported to be $366.4 m in FY, 2016 which is a 9% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$263.4 m$301.5 m$336.1 m$366.4 m

Revenue growth, %

14%11%9%

Cost of goods sold

$160.9 m$185.6 m$204.7 m$214.4 m

Gross profit

$102.5 m$115.9 m$131.5 m$152 m

Gross profit Margin, %

39%38%39%41%

Operating expense total

$120.3 m$138.1 m$146.1 m$156.3 m

EBIT

($17.8 m)($22.2 m)($14.6 m)($4.3 m)

EBIT margin, %

(7%)(7%)(4%)(1%)

Interest expense

$611 k$863 k$1.1 m$1 m

Pre tax profit

($18.8 m)($23.1 m)($15.2 m)($6.2 m)

Income tax expense

($245 k)$1.3 m$1.1 m$1.1 m

Net Income

($18.6 m)($24.3 m)($16.3 m)($7.3 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$84.1 m$52.9 m$59.1 m$59.6 m

Accounts Receivable

$20.2 m$24.1 m$25.2 m$32.3 m

Inventories

$4 m$6.8 m$6.3 m$6.1 m

Current Assets

$146.1 m$129.2 m$128.9 m$144.9 m

PP&E

$52.5 m$66.6 m$66.7 m$61.6 m

Goodwill

$41.8 m$41.8 m$42.7 m$42.6 m

Total Assets

$307 m$309.7 m$306.9 m$317.2 m

Accounts Payable

$14.6 m$13.8 m$10.8 m$14.2 m

Total Debt

$1.1 m$941 k$2 m$1.6 m

Current Liabilities

$37.6 m$44.8 m$42.7 m$49.3 m

Additional Paid-in Capital

$567.5 m$593.1 m$612.5 m$631.2 m

Retained Earnings

($363.5 m)($387.5 m)($402.8 m)($407.6 m)

Total Equity

$194.8 m$191.6 m$193.5 m$202 m

Debt to Equity Ratio

0 x0 x0 x0 x

Debt to Assets Ratio

0 x0 x0 x0 x

Financial Leverage

1.6 x1.6 x1.6 x1.6 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($18.6 m)($24.3 m)($16.3 m)($7.3 m)

Depreciation and Amortization

$24.8 m$27.7 m$30.7 m$32.6 m

Accounts Receivable

($1.1 m)($4.2 m)($1.1 m)($7.4 m)

Inventories

($20 m)($35 m)($12 m)($31 m)

Accounts Payable

($2.2 m)($212 k)($2.8 m)$3.5 m

Cash From Operating Activities

($10.1 m)($20.3 m)$10.5 m$4.6 m

Purchases of PP&E

($16.2 m)($20.1 m)($11.5 m)($8.8 m)

Cash From Investing Activities

($18.5 m)($20.1 m)($10.9 m)($9.4 m)

NxStage Medical Market Value History

NxStage Medical Job Categories

NxStage Medical Median Salaries

Source: 27 public H-1B filings from NxStage Medical

NxStage Medical Online Presence

NxStage Medical Company Life

You may also be interested in